1,786 results on '"Lo, Chung-Mau"'
Search Results
2. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
3. High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter
4. Defining the surgical management for non-colorectal liver metastases
5. Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases
6. Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma
7. Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts
8. Long-term survival in colorectal liver metastasis
9. Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma—a retrospective study
10. Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer
11. Novel Benchmark for Adult-to-Adult Living-donor Liver Transplantation: Integrating Eastern and Western Experiences
12. HFE promotes mitotic cell division through recruitment of cytokinetic abscission machinery in hepatocellular carcinoma
13. Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
14. Routine use of ICG to enhance operative safety in emergency laparoscopic cholecystectomy: a randomized controlled trial
15. Impact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation
16. The role of stereotactic body radiotherapy in hepatocellular carcinoma: guidelines and evidences
17. Impact of preoperative biliary drainage on postoperative outcomes in hilar cholangiocarcinoma
18. Role of Intrahepatic Regional Immunity in Post-Transplant Cancer Recurrence
19. Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma—a propensity score matched analysis
20. Relevance of chemotherapy and margin status in colorectal liver metastasis
21. The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants
22. Compromised AMPK-PGCIα Axis Exacerbated Steatotic Graft Injury by Dysregulating Mitochondrial Homeostasis in Living Donor Liver Transplantation
23. 415.1: PGC1alpha-Mediated Metabolic Reprogramming Facilitates M1 Macrophage Polarization During Steatotic Allograft Dysfunction After Liver Transplantation
24. Pure laparoscopic versus open major hepatectomy for hepatocellular carcinoma with liver F4 cirrhosis without routine Pringle maneuver – A propensity analysis in a single center
25. Determining the optimal timing of liver transplant for pediatric patients after Kasai portoenterostomy based on disease severity scores
26. Living-Donor Transplantation with Right Lobe (With or Without Middle Hepatic Vein)
27. Glutathione S-transferase A2 promotes hepatocellular carcinoma recurrence after liver transplantation through modulating reactive oxygen species metabolism
28. Regional trauma system development in Shenzhen, China: an 8-year journey
29. Cytomegalovirus Latency Exacerbated Small-for-size Liver Graft Injury Through Activation of CCL19/CCR7 in Hepatic Stellate Cells
30. Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway
31. Survival analysis of breast cancer liver metastasis treated by hepatectomy: A propensity score analysis for Chinese women in Hong Kong
32. A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance
33. Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma
34. The Risk of Going Small: Lowering GRWR and Overcoming Small-For-Size Syndrome in Adult Living Donor Liver Transplantation
35. Response to the Comment on “The Risk of Going Small: Lowering GRWR and Overcoming Small-for-Size Syndrome in Adult Living Donor Liver Transplantation”
36. Anatomical Versus Nonanatomical Resection for Colorectal Liver Metastasis
37. Solitary extraovarian primary peritoneal carcinoma with direct invasion into the liver, diaphragm and lung without peritoneal dissemination or distant metastasis
38. Donor ductal anomaly is not a contraindication to right liver lobe donation
39. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis
40. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis
41. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma
42. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection – A 13-year cohort in a tertiary center
43. Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
44. Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling
45. ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation
46. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
47. Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence.
48. A machine learning model for colorectal liver metastasis post-hepatectomy prognostications
49. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma: A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy
50. The Risk of Going Small: Lowering GRWR and Overcoming Small-For-Size Syndrome in Adult Living Donor Liver Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.